Compare COHR & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COHR | LH |
|---|---|---|
| Founded | 1971 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.9B | 22.1B |
| IPO Year | 1987 | N/A |
| Metric | COHR | LH |
|---|---|---|
| Price | $164.62 | $269.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 13 |
| Target Price | $137.77 | ★ $299.00 |
| AVG Volume (30 Days) | ★ 5.4M | 1.0M |
| Earning Date | 11-05-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 1.07% |
| EPS Growth | N/A | ★ 98.36 |
| EPS | 0.76 | ★ 10.19 |
| Revenue | $6,043,358,000.00 | ★ $13,765,300,000.00 |
| Revenue This Year | $10.48 | $10.81 |
| Revenue Next Year | $11.20 | $4.45 |
| P/E Ratio | $215.84 | ★ $26.39 |
| Revenue Growth | ★ 20.80 | 8.28 |
| 52 Week Low | $45.58 | $209.38 |
| 52 Week High | $168.57 | $293.72 |
| Indicator | COHR | LH |
|---|---|---|
| Relative Strength Index (RSI) | 65.44 | 54.23 |
| Support Level | $142.46 | $257.71 |
| Resistance Level | $155.82 | $270.98 |
| Average True Range (ATR) | 10.82 | 5.88 |
| MACD | 0.49 | 1.55 |
| Stochastic Oscillator | 89.74 | 92.31 |
Coherent Corp engaged in materials, networking, and lasers, is a vertically integrated manufacturing company that develops, manufactures, and markets engineered materials, optoelectronic components and devices, and lasers for use in the industrial, communications, electronics and instrumentation markets. The firm operates in three segments Networking, Materials, and Lasers Segment. It generates maximum revenue from Networking segment. The company geographically operates in North America. Europe, China, Japan and Rest of the world.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.